Danaher Co. (DHR) Expected to Post Quarterly Sales of $4.96 Billion

Wall Street analysts predict that Danaher Co. (NYSE:DHR) will report sales of $4.96 billion for the current quarter, Zacks Investment Research reports. Eight analysts have made estimates for Danaher’s earnings. The highest sales estimate is $5.02 billion and the lowest is $4.91 billion. Danaher reported sales of $4.58 billion during the same quarter last year, which indicates a positive year-over-year growth rate of 8.3%. The firm is scheduled to issue its next earnings report before the market opens on Tuesday, January 30th.

According to Zacks, analysts expect that Danaher will report full year sales of $4.96 billion for the current year, with estimates ranging from $18.15 billion to $18.26 billion. For the next year, analysts anticipate that the company will report sales of $19.10 billion per share, with estimates ranging from $18.83 billion to $19.23 billion. Zacks Investment Research’s sales calculations are an average based on a survey of research analysts that follow Danaher.

Danaher (NYSE:DHR) last announced its earnings results on Thursday, October 19th. The conglomerate reported $1.00 EPS for the quarter, beating analysts’ consensus estimates of $0.95 by $0.05. The business had revenue of $4.53 billion for the quarter, compared to analysts’ expectations of $4.47 billion. Danaher had a net margin of 13.36% and a return on equity of 11.29%. The company’s quarterly revenue was up 9.6% on a year-over-year basis. During the same period in the previous year, the company posted $0.87 EPS.

DHR has been the topic of a number of recent research reports. Credit Suisse Group reaffirmed a “hold” rating and issued a $99.00 target price on shares of Danaher in a report on Tuesday, December 19th. Zacks Investment Research raised shares of Danaher from a “hold” rating to a “buy” rating and set a $97.00 target price on the stock in a report on Thursday, October 5th. Robert W. Baird reaffirmed a “buy” rating and issued a $99.00 target price on shares of Danaher in a report on Friday, December 15th. Morgan Stanley reaffirmed an “overweight” rating and issued a $95.00 target price (up from $86.00) on shares of Danaher in a report on Friday, October 6th. Finally, Cowen reaffirmed a “buy” rating and issued a $90.00 target price on shares of Danaher in a report on Wednesday, October 4th. One research analyst has rated the stock with a sell rating, six have given a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $95.86.

In other Danaher news, CFO Daniel L. Comas sold 88,184 shares of the business’s stock in a transaction on Monday, October 23rd. The shares were sold at an average price of $91.02, for a total value of $8,026,507.68. Following the transaction, the chief financial officer now directly owns 227,816 shares of the company’s stock, valued at approximately $20,735,812.32. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CAO Robert S. Lutz sold 11,189 shares of the business’s stock in a transaction on Monday, October 23rd. The shares were sold at an average price of $91.66, for a total transaction of $1,025,583.74. Following the completion of the transaction, the chief accounting officer now directly owns 18,314 shares in the company, valued at $1,678,661.24. The disclosure for this sale can be found here. Insiders sold a total of 273,810 shares of company stock worth $25,218,813 over the last three months. 12.20% of the stock is currently owned by corporate insiders.

Several large investors have recently bought and sold shares of DHR. Beach Investment Management LLC. grew its stake in shares of Danaher by 1,013.8% during the 2nd quarter. Beach Investment Management LLC. now owns 53,460 shares of the conglomerate’s stock worth $4,511,000 after purchasing an additional 48,660 shares during the period. Dupont Capital Management Corp grew its stake in shares of Danaher by 27.1% during the 2nd quarter. Dupont Capital Management Corp now owns 38,041 shares of the conglomerate’s stock worth $3,210,000 after purchasing an additional 8,118 shares during the period. LMR Partners LLP acquired a new position in shares of Danaher during the 2nd quarter worth $1,206,000. Fishman Jay A Ltd. MI grew its stake in shares of Danaher by 0.9% during the 2nd quarter. Fishman Jay A Ltd. MI now owns 21,442 shares of the conglomerate’s stock worth $1,809,000 after purchasing an additional 200 shares during the period. Finally, Dowling & Yahnke LLC grew its stake in shares of Danaher by 1.9% during the 2nd quarter. Dowling & Yahnke LLC now owns 41,007 shares of the conglomerate’s stock worth $3,461,000 after purchasing an additional 778 shares during the period. 76.11% of the stock is currently owned by institutional investors and hedge funds.

Shares of Danaher (DHR) traded up $0.82 during trading on Friday, hitting $100.56. 2,278,162 shares of the stock were exchanged, compared to its average volume of 2,250,000. The firm has a market cap of $69,950.00, a PE ratio of 29.93, a price-to-earnings-growth ratio of 2.16 and a beta of 1.03. Danaher has a fifty-two week low of $78.97 and a fifty-two week high of $100.88. The company has a quick ratio of 1.00, a current ratio of 1.43 and a debt-to-equity ratio of 0.42.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Friday, December 29th will be paid a $0.14 dividend. The ex-dividend date of this dividend is Thursday, December 28th. This represents a $0.56 annualized dividend and a yield of 0.56%. Danaher’s dividend payout ratio is currently 16.67%.

WARNING: This piece was originally published by American Banking News and is owned by of American Banking News. If you are accessing this piece on another site, it was illegally stolen and republished in violation of U.S. and international trademark and copyright legislation. The correct version of this piece can be read at https://www.americanbankingnews.com/2018/01/20/danaher-co-dhr-expected-to-post-quarterly-sales-of-4-96-billion.html.

About Danaher

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Get a free copy of the Zacks research report on Danaher (DHR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply